Value of fluorodeoxyglucose–positron emission tomography (FDG-PET) in the detection of residual disease after treatment in Hodgkin’s disease patients.
| . | . | . | . | . | PFS@ 1 year . | |
|---|---|---|---|---|---|---|
| Author (ref) . | Number . | NPV . | PPV . | Mean FU (range, mo.) . | PET− . | PET+ . |
| Abbreviations: NPV, negative predictive value; PPV, positive predictive value; FU, follow up; PFS, progression free survival; ns, not specified; PET+, residual disease on PET; PET−, complete metabolic response | ||||||
| Hueltenschmidt (9) | 63 | 98% | 86% | 24 (3–41) | ns | ns |
| Spaepen (10) | 60 | 91% | 100% | 32 (13–50) | 95% | 40% |
| Dittman (11) | 24 | 94% | 88% | > 6 | ns | ns |
| Naumann (12) | 43 | 100% | 25% | 35 (15–58) | 100% | 75% |
| Weihrauch (13) | 29 | 84% | 60% | 28 (16–68) | 95% | 40% |
| De Wit (14) | 37 | 96% | 46% | 26 (2–34) | 100% | 75% |
| Lavely (15) | 20 | 81% | ns | 36 (9–75) | ns | ns |
| Guay (16) | 48 | 92% | 92% | ns | 100% | 45% |
| Jerusalem (17) | 36 | 94% | 100% | ns | ns | ns |
| . | . | . | . | . | PFS@ 1 year . | |
|---|---|---|---|---|---|---|
| Author (ref) . | Number . | NPV . | PPV . | Mean FU (range, mo.) . | PET− . | PET+ . |
| Abbreviations: NPV, negative predictive value; PPV, positive predictive value; FU, follow up; PFS, progression free survival; ns, not specified; PET+, residual disease on PET; PET−, complete metabolic response | ||||||
| Hueltenschmidt (9) | 63 | 98% | 86% | 24 (3–41) | ns | ns |
| Spaepen (10) | 60 | 91% | 100% | 32 (13–50) | 95% | 40% |
| Dittman (11) | 24 | 94% | 88% | > 6 | ns | ns |
| Naumann (12) | 43 | 100% | 25% | 35 (15–58) | 100% | 75% |
| Weihrauch (13) | 29 | 84% | 60% | 28 (16–68) | 95% | 40% |
| De Wit (14) | 37 | 96% | 46% | 26 (2–34) | 100% | 75% |
| Lavely (15) | 20 | 81% | ns | 36 (9–75) | ns | ns |
| Guay (16) | 48 | 92% | 92% | ns | 100% | 45% |
| Jerusalem (17) | 36 | 94% | 100% | ns | ns | ns |